Jane Street’s Praxis Precision Medicines PRAX Stock Holding History

Jane Street’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.14M	Sell	27,300 -20,300	-43%	-$6.43M	﹤0.01%	2939
2026 Q1	$15.3M	Sell	47,600 -1,100	-2%	-$340K	﹤0.01%	2035
2025 Q4	$14.4M	Buy	48,700 +32,500	+201%	+$6.05M	﹤0.01%	1918
2025 Q3	$859K	Buy	+16,200	New	+$785K	﹤0.01%	6652
2025 Q2	–	Sell	-13,100	Closed	-$496K	–	10596
2025 Q1	$496K	Buy	13,100 +700	+6%	+$43.7K	﹤0.01%	6877
2024 Q4	$954K	Sell	12,400 -7,800	-39%	-$564K	﹤0.01%	5480
2024 Q3	$1.16M	Buy	20,200 +4,700	+30%	+$254K	﹤0.01%	5596
2024 Q2	$641K	Buy	+15,500	New	+$733K	﹤0.01%	6616

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jane Street's PRAX Position: Q2 2026 in Review

Jane Street opened a new position in Praxis Precision Medicines (PRAX) in Q2 2026: 1,008 shares worth $337K. The stake represents ﹤0.01% of the portfolio and ranks #8953 among its holdings. This is a return to the name: Jane Street previously reported a position in PRAX as recently as Q3 2025.

Jane Street first reported a position in PRAX in Q2 2022 and has held it in 12 quarters since. The position peaked at $2.87M in Q1 2024. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Jane Street held 1,008 shares of Praxis Precision Medicines worth $337K as of Q2 2026.
Praxis Precision Medicines was a new Jane Street position in Q2 2026.
Praxis Precision Medicines made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8953 holding.
Jane Street first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 12 quarters since.
Jane Street's Praxis Precision Medicines position peaked at $2.87M in Q1 2024.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.